AbbVie Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 67250.48, 72815.36, 78492.53, 83446, 84430.9 ], "ebit_estimate": [ 31256.92, 35600.86, 39809.17, 43283.96, 44173.75 ], "ebitda_estimate": [ 33544.28, 37952.56, 41723.57, 44688.57, 38952 ], "net_income_estimate": [ 25201.09, 28775.73, 32053.79, 34827.32, 35288.03 ], "per_share_eps_estimate": [ 8.22, 10.66, 12.88, 15.03, 16.39 ], "eps_nri_estimate": [ 14.21, 16.23, 18, 19.7, 20.03 ], "dividend_estimate": [ 6.83, 7.18, 7.52, 8.03, 8.54 ], "book_value_per_share_estimate": [ 0.54, 5.28, 11.53, 20.08, 31.77 ], "pretax_income_estimate": [ 29433.52, 34505.77, 38551.15, 41755.5, 42322.86 ], "operating_cash_flow_per_share_estimate": [ 13.37, 15.14, 18.16, 22.62, 23.62 ], "roa_estimate": [ 13, 15.2, 23.1, 17.9, 17.7 ], "roe_estimate": [ 393.3, 444.95, 200.41, 117.4, 73.1 ], "gross_margin_estimate": [ 83.11, 83.38, 84.72, 84.96, 85.02 ], "operating_cash_flow_estimate": [ 23725.83, 26865.81, 32216.73, 40127.88, 41901.88 ], "pettm_estimate": [ 30.19, 23.28, 19.27, 16.5, 15.13 ], "long_term_growth_rate_mean": 20.89, "long_term_revenue_growth_rate_mean": "8.63", "future_per_share_eps_estimate_growth": 70.75, "future_eps_nri_estimate_growth": 20.89, "future_revenue_estimate_growth": 8.63, "future_ebit_estimate_growth": 18.33, "future_ebitda_estimate_growth": 18.8, "future_dividend_estimate_growth": 4.28, "future_net_income_estimate_growth": 20.92, "future_pretax_income_estimate_growth": 20.73, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": 20.09, "future_roe_estimate_growth": -24.77, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": 18.57 }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 16750.79, 17322.96, 18146.64, 16036.58, 18125.48, 18694.49, 19554.75 ], "ebit_estimate": [ 8331.59, 8569.81, 8845.95, 7498.5, 9134.5, 9428, 9690.5 ], "ebitda_estimate": [ 8394.67, 8849.67, 8928, null, null, null, null ], "net_income_estimate": [ 6616.58, 6801.04, 7059.64, 5863, 7299.5, 7560.5, 7802.5 ], "per_share_eps_estimate": [ 2.43, 2.64, 3.04, 1.92, 2.82, 3.04, 3.23 ], "eps_nri_estimate": [ 3.73, 3.84, 4, 3.28, 4.07, 4.19, 4.41 ], "dividend_estimate": [ 1.73, 1.73, 1.73, 1.8, 1.8, 1.8, 1.8 ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ 7690.46, 7926.32, 8182.88, 6965.5, 8694, 9006.5, 9295.5 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ 84.32, 84.05, 84.33, 84.2, 84.2, 84.2, 84.2 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 24.73, 23.81, 22.93, 22.54, null, null, null ], "long_term_growth_rate_mean": 20.89, "long_term_revenue_growth_rate_mean": "8.63", "future_per_share_eps_estimate_growth": 70.75, "future_eps_nri_estimate_growth": 20.89, "future_revenue_estimate_growth": 8.63, "future_ebit_estimate_growth": 18.33, "future_ebitda_estimate_growth": 18.8, "future_dividend_estimate_growth": 4.28, "future_net_income_estimate_growth": 20.92, "future_pretax_income_estimate_growth": 20.73, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": 20.09, "future_roe_estimate_growth": -24.77, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": 18.57 }